Fidelity reviews Q2 for its International Small Cap Fund, highlighting key wins and misses. See how it's adapting to global shifts. Explore the full update.

The Heartland Small Cap Value Strategy posted an outstanding second quarter, beating its benchmark and has continued to ...

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street ...

Ophir Asset Management’s Aussie small cap fund returned 39 per cent last financial year. Here’s where they’re investing this ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.

At the recent Pinnacle Summit, four fund managers reveal their top ASX stock picks focusing on fundamentals and long-term ...

Improving domestic growth, rising liquidity, and potential rate cuts are expected to aid recovery, but the ‘real concern is ...

You don't have to be Warren Buffett to build generational wealth in the stock market. All you need to do is focus on ...

The data mining and artificial intelligence (AI) specialist is firing on all cylinders, but the answer is still complicated.

Opportunities in traditional pharma companies with a focus on domestic formulations and US generics are drying up because of ...

Veteran investor Dolly Khanna's portfolio delivered stellar returns in FY26 so far, rising 42% to Rs 555 crore. Mangalore ...